共 50 条
- [1] Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (09):
- [3] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01):
- [4] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study [J]. Allergy, Asthma & Clinical Immunology, 20
- [5] Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study [J]. JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 45 - 60
- [8] Real-world observational study of the evaluation of inhaler techniques in asthma patients [J]. ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2021, 39 (02): : 96 - 102
- [9] Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08): : 2630 - +
- [10] Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada [J]. PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 725 - 735